Business Wire

TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology

Share

TriLink BioTechnologies (TriLink®), a Maravai™ LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has signed a non-exclusive License and Supply Agreement with Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries. This agreement with Lonza strengthens TriLink’s objective to drive greater access to CleanCap® mRNA capping technologies as the demand for mRNA – a promising therapeutic modality – continues to grow.

According to the terms of the agreement, TriLink® will supply its patented CleanCap® M6, CleanCap® AG 3’OMe, CleanCap® AG, and CleanCap® AU cap analogs for use in Lonza’s global mRNA development and manufacturing services, from pre-clinical through Phase III programs. CleanCap® technology is a one-pot solution with over 95% capping efficiency that streamlines mRNA production processes when compared to legacy capping methods.

“CleanCap® technology is accelerating programs from discovery to the clinic via improved mRNA function, streamlined manufacturing, and maximized capped material yield,” shared Drew Burch, President of Nucleic Acid Production at TriLink. “We’re thrilled to offer our innovative capping solutions to Lonza and its customers.”

Since its launch in 2017, TriLink’s CleanCap® capping technology has continued to advance the mRNA capping industry and is used in a majority of approved mRNA and saRNA vaccines. In May 2023, TriLink introduced its most robust CleanCap analog to date, CleanCap® M6, with studies indicating increased mRNA expression by more than 30% versus enzymatic capping methods.

About TriLink BioTechnologies

TriLink BioTechnologies, a Maravai LifeSciences company, is a global leader in nucleic acid and mRNA solutions. TriLink delivers unrivaled chemical and biological experience, CDMO services, and high-quality readymade and custom materials, including its patented CleanCap® mRNA capping technology. Pharmaceutical leaders, biotech disruptors, and world governments depend on TriLink to meet their greatest challenges, from delivering the COVID-19 vaccine at warp speed, to empowering innovative treatments in oncology, infectious diseases, cardiology, and neurological disorders, to enabling future pandemic response plans.

For more information, visit trilinkbiotech.com.

About Maravai LifeSciences

Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world’s leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies.

For more information about Maravai LifeSciences, visit maravai.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Liz Robinson of CG Life
TriLink BioTechnologies
lrobinson@cglife.com
312-997-2436

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Grid Dynamics Achieves the Amazon Web Services Machine Learning Competency20.5.2024 23:05:00 EEST | Press release

Grid Dynamics Holdings, Inc. (NASDAQ: GDYN) (Grid Dynamics), a leading provider of technology consulting, platform and product engineering, AI, and advanced analytics services, today proudly announced it has achieved the prestigious Amazon Web Services (AWS) Machine Learning Competency. This newest designation validates Grid Dynamics’ expertise in leveraging AWS technologies to drive innovation in data science and the commitment to deliver cutting-edge solutions for customers. Attaining the AWS Machine Learning Competency underscores Grid Dynamics’ expertise in machine learning on AWS, assuring customers of the company's capability to accelerate the seamless delivery of superior solutions that maximize AWS services. From predictive maintenance solutions for manufacturing companies to personalized recommendation systems for e-commerce platforms, Grid Dynamics empowers businesses to unlock valuable insights from their data and enhance decision-making processes. Grid Dynamics has proven e

Carestream Introduces Image Suite MR 10 Software to Enhance Imaging Experience for CR and DR Imaging Systems20.5.2024 22:50:00 EEST | Press release

Carestream launches its Image Suite MR 10 Software to help deliver a boost to productivity and efficiency while enabling a more user-friendly imaging experience for radiographers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240520143395/en/ (Photo: Business Wire) Carestream’s Image Suite Software helps optimize imaging performance for both Computed Radiography (CR) and Digital Radiography (DR) imaging systems, with a user-friendly interface, specialized measurement tools, and an optional Mini-PACS module. “Our Image Suite Software is purpose-built to deliver the benefits radiographers need to focus on what matters most—their patients,” said Praveen Rajgopal, Global Product Marketing Manager . “Image Suite MR 10 helps push the envelope further for even more focus on patient care.” New features to help deliver improved productivity and efficiency include: Focus HD Detector Support1—These support features help boost efficien

DentalMonitoring Sets New Standard In Orthodontic Remote Monitoring With De Novo Approval By the U.S. Food and Drug Administration (FDA).20.5.2024 22:16:00 EEST | Press release

DentalMonitoring®, the leader in AI-powered remote monitoring for orthodontic treatment, has received De Novo approval from the U.S. Food and Drug Administration (FDA) for the DentalMonitoring solution to be used by orthodontists in optimizing clinical care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240520240852/en/ DentalMonitoring Sets New Standard in Orthodontic Remote Monitoring with De Novo Approval by the U.S. Food and Drug Administration (FDA) (Graphic: Business Wire) DentalMonitoring is a medical device software using image processing algorithms to analyze pictures of the oral cavity (hereinafter Scans). Scans are taken using the DM App, a smartphone, and the manufacturer’s proprietary hardware products. DentalMonitoring is indicated for use for patients over the age of 6 and reports results solely on permanent teeth. The product is designed to assist healthcare professionals in remotely monitoring dental treatm

Ohmium Selected to Provide 10MW PEM Electrolyzers for First Green Hydrogen Project in Croatia20.5.2024 22:04:00 EEST | Press release

Ohmium International (“Ohmium”), a leading green hydrogen company that designs, manufactures, and deploys advanced Proton Exchange Membrane (PEM) electrolyzers, is pleased to announce that it was selected to equip the first green hydrogen project in Croatia. Ohmium was selected to serve as the PEM electrolyzer supplier for IVICOM, a leading Croatian engineering and construction company, on a project to build a 10MW green hydrogen plant at the INA Rijeka Refinery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240520820657/en/ INA Rijeka Refinery in Kostrena, Croatia (Photo: Business Wire) The project will pair Ohmium’s PEM electrolyzers with a new solar power plant to produce green hydrogen to help decarbonize INA’s Rijeka Refinery and supply sustainable fuel for Croatia’s growing transportation market. The green hydrogen project and affiliated solar plant are supported by the Croatian government’s Recovery and Resilience Fa

Lenovo Supercharges Next Gen Copilot+ PCs with Latest Yoga Slim 7x and ThinkPad T14s Gen 620.5.2024 21:20:00 EEST | Press release

Today, Lenovo™ launched the Lenovo Yoga™ Slim 7x and Lenovo ThinkPad™ T14s Gen 6, its first next generation Copilot+ PCs powered by Snapdragon® X Elite. As the PC industry enters a new phase of the artificial intelligence era, Lenovo is poised to offer new levels of personalization in personal computing across its PC portfolio. Intelligent software-powered local processing of tasks, and increased productivity, creativity, and security, these Copilot+ PC’s combine to deliver a whole new experience in PC interaction. Lenovo is expanding its already comprehensive portfolio of AI-ready devices, software, and optimized services with two new laptops for consumers and business users—the Lenovo Yoga Slim 7x and the Lenovo ThinkPad T14s Gen 6. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240520017996/en/ Lenovo ThinkPad T14s Gen 6 (Photo: Business Wire) Powered by Qualcomm Technologies’ new Snapdragon X Elite processor featuring th

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye